Form 8-K - Current report:
SEC Accession No. 0001193125-25-144151
Filing Date
2025-06-23
Accepted
2025-06-23 07:00:19
Documents
12
Period of Report
2025-06-13
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d857375d8k.htm   iXBRL 8-K 21684
  Complete submission text file 0001193125-25-144151.txt   135204

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lyra-20250613.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lyra-20250613_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lyra-20250613_pre.xml EX-101.PRE 11268
15 EXTRACTED XBRL INSTANCE DOCUMENT d857375d8k_htm.xml XML 3662
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39273 | Film No.: 251062940
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)